Navidea Biopharmaceuticals, Inc. (NAVBQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Feb 11, 2026
NAVBQ Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
Cash & Equivalents | 3.86 | 2 | 4.23 | 2.67 | 1.05 | 3.48 |
Short-Term Investments | - | - | - | - | - | 0.8 |
Cash & Short-Term Investments | 3.86 | 2 | 4.23 | 2.67 | 1.05 | 4.28 |
Cash Growth | -16.00% | -52.83% | 58.43% | 155.02% | -75.51% | -6.91% |
Accounts Receivable | - | 0 | 0.09 | 0.06 | 0.08 | 0.02 |
Other Receivables | 0.03 | 0 | 0 | 2.93 | 1.13 | 0.6 |
Receivables | 0.03 | 0 | 0.09 | 2.99 | 1.21 | 0.62 |
Inventory | 0.46 | 0.43 | 0.15 | 0.17 | - | - |
Prepaid Expenses | 0.15 | 0.78 | 0.91 | 0.7 | 0.66 | 0.7 |
Total Current Assets | 4.5 | 3.2 | 5.38 | 6.53 | 2.92 | 5.6 |
Property, Plant & Equipment | 0.12 | 0.16 | 0.25 | 0.38 | 0.31 | 0.16 |
Other Intangible Assets | 1.06 | 1 | 0.79 | 0.62 | 0.39 | 0.43 |
Other Long-Term Assets | 0.01 | 0.01 | 0.23 | 0.23 | 0.54 | 0.84 |
Total Assets | 5.7 | 4.37 | 6.64 | 7.76 | 4.15 | 7.02 |
Accounts Payable | 2.07 | 2.12 | 1.42 | 1.16 | 1.11 | 0.42 |
Accrued Expenses | 3.39 | 6.46 | 3.11 | 2.48 | 2.14 | 2.5 |
Current Portion of Long-Term Debt | 1.25 | 0.54 | 0.45 | 0.75 | 0.31 | 0.32 |
Current Portion of Leases | 0.01 | 0.02 | 0.28 | 0.29 | 0.25 | - |
Current Unearned Revenue | 0.8 | 0.8 | 0.04 | - | - | - |
Other Current Liabilities | 0.46 | 0 | - | 0.03 | 0.01 | 0.13 |
Total Current Liabilities | 7.98 | 9.94 | 5.3 | 4.72 | 3.82 | 3.38 |
Long-Term Debt | - | 1.87 | - | - | - | - |
Long-Term Leases | 0 | 0 | 0.02 | 0.3 | 0.51 | - |
Long-Term Unearned Revenue | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 |
Other Long-Term Liabilities | - | - | - | - | - | 0.53 |
Total Liabilities | 8.68 | 12.51 | 6.02 | 5.71 | 5.03 | 4.61 |
Common Stock | 0.29 | 0.22 | 0.22 | 0.22 | 0.21 | 0.2 |
Additional Paid-In Capital | 382.35 | 379.34 | 370.46 | 375.43 | 345.85 | 338.27 |
Retained Earnings | -385.91 | -388 | -370.79 | -359.06 | -347.67 | -336.72 |
Comprehensive Income & Other | - | - | - | -4.97 | 0 | -0 |
Total Common Equity | -3.27 | -8.44 | -0.11 | 11.62 | -1.61 | 1.74 |
Minority Interest | 0.29 | 0.29 | 0.73 | 0.73 | 0.73 | 0.67 |
Shareholders' Equity | -2.98 | -8.14 | 0.62 | 2.05 | -0.88 | 2.41 |
Total Liabilities & Equity | 5.7 | 4.37 | 6.64 | 7.76 | 4.15 | 7.02 |
Total Debt | 1.26 | 2.44 | 0.75 | 1.34 | 1.07 | 0.32 |
Net Cash (Debt) | 2.61 | -0.44 | 3.48 | 1.33 | -0.02 | 3.96 |
Net Cash Growth | -6.32% | - | 160.96% | - | - | 76.83% |
Net Cash Per Share | 0.05 | -0.01 | 0.12 | 0.06 | -0.00 | 0.46 |
Filing Date Shares Outstanding | 99.99 | 32.76 | 30.2 | 28.51 | 20.42 | 10.03 |
Total Common Shares Outstanding | 99.99 | 32.6 | 30.18 | 27.09 | 19.22 | 10.01 |
Working Capital | -3.48 | -6.74 | 0.08 | 1.81 | -0.9 | 2.22 |
Book Value Per Share | -0.03 | -0.26 | -0.00 | 0.43 | -0.08 | 0.17 |
Tangible Book Value | -4.34 | -9.44 | -0.89 | 11 | -2 | 1.31 |
Tangible Book Value Per Share | -0.04 | -0.29 | -0.03 | 0.41 | -0.10 | 0.13 |
Machinery | - | 0.49 | 0.52 | 0.51 | 0.87 | 0.9 |
Leasehold Improvements | - | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.